The effect of Human Immunodeficiency Virus (HIV) incidence of mass treatment in combination with syndromic management of sexually transmitted infections, with or without acyclovir

ISRCTN	ISRCTN87389715
DOI	https://doi.org/10.1186/ISRCTN87389715
Protocol serial number	G0000527
Sponsor	Medical Research Council (MRC) (UK)
Funder	Applied for funding to UK Medical Research Council & other sources of funding but unsucessfully.

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Dr Anatoli Kamali
Scientific

Medical Research Council Programme on AIDS
Uganda Virus Research Institute
PO Box 49
Entebbe
Uganda

Phone	+256 (0) 41 320042/320272
Email	mrc@starcom.co.ug

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title
Study objectives	Not provided at time of registration
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	HIV, Acquired Immunodeficiency Syndrome (AIDS)
Intervention	Not provided at time of registration
Intervention type	Drug
Phase	Not Specified
Drug / device / biological / vaccine name(s)	acyclovir
Primary outcome measure(s)	Not provided at time of registration
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	31/12/2001
Reason abandoned (if study stopped)	Lack of funding

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Key inclusion criteria	Not provided at time of registration
Key exclusion criteria	Not provided at time of registration
Date of first enrolment	01/01/2001
Date of final enrolment	31/12/2001

Medical Research Council Programme on AIDS

Entebbe
Uganda

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan